A Systematic Review of MDMA’s Effects on Social Cognition in Placebo-Controlled Trials
Abstract
Background 3,4-Methylenedioxymethamphetamine (MDMA) is associated with distinctive prosocial and empathogenic effects, yet the consistency and scope of its impact on social cognition in humans remain unclear. Although numerous placebo-controlled studies have examined MDMA’s acute social effects, findings vary widely across subjective and behavioural domains.
Methods We conducted a systematic review of placebo-controlled studies investigating the acute effects of MDMA on social cognition in adults. Outcomes included self-reported social and emotional experience, task-based measures of social cognition and behaviour, and relevant physiological and neurobiological indices. Studies administering MDMA as the sole intervention were included.
Results Across 75 studies, MDMA reliably enhanced subjective social experience, including feelings of sociability, emotional openness, closeness, and emotional empathy. In contrast, behavioural manifestations of prosociality, such as cooperation and trust in economic or performance-based tasks, were inconsistent and strongly context dependent. Behavioural and neuroimaging measures showed reduced accuracy in identifying negative social cues, including fear and anger, but no study used signal-detection metrics to discriminate genuine perceptual blunting from a shift in response criterion. Neuroimaging findings were from small, methodologically heterogeneous samples.
Conclusions MDMA consistently alters how social interactions are experienced, but subjective changes do not reliably translate into observable prosocial behaviour. MDMA reduces accuracy in identifying negative social cues, particularly fear and anger, but whether this reflects a specific blunting of threat processing or a shift in response bias and salience detection remains unresolved. Clarifying these mechanisms has implications for understanding MDMA’s therapeutic potential in conditions characterised by heightened social threat and avoidance.
Related
- Biologics and small molecules for perianal Crohn’s disease: a systematic review and meta-analyses of randomized placebo-controlled trials
- Virtual Placebo: a scoping review of control conditions in randomized controlled trials of psychological immersive virtual reality interventions
- New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review
- Aperiodic EEG features of cognition: a systematic review
- Placebo effects of caffeine on sport performance: a systematic review and meta-analysis.
BibTeX
@misc{burmester2026systematic,
title = {{A Systematic Review of MDMA’s Effects on Social Cognition in Placebo-Controlled Trials}},
author = {Victoria Burmester and David Nutt and Laura Aggett and Chloe Wong and Sofia Bonito and Sophie Leigh and Tessa Bo Watford and Dasha Nicholls},
howpublished = {PsyArXiv},
year = {2026},
month = sep,
doi = {10.31234/osf.io/sgdau_v3},
url = {https://osf.io/preprints/psyarxiv/sgdau_v3/},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - A Systematic Review of MDMA’s Effects on Social Cognition in Placebo-Controlled Trials
AU - Victoria Burmester
AU - David Nutt
AU - Laura Aggett
AU - Chloe Wong
AU - Sofia Bonito
AU - Sophie Leigh
AU - Tessa Bo Watford
AU - Dasha Nicholls
PY - 2026
DA - 2026/09/11
PB - PsyArXiv
DO - 10.31234/osf.io/sgdau_v3
UR - https://osf.io/preprints/psyarxiv/sgdau_v3/
AB - Background 3,4-Methylenedioxymethamphetamine (MDMA) is associated with distinctive prosocial and empathogenic effects, yet the consistency and scope of its impact on social cognition in humans remain unclear. Although numerous placebo-controlled studies have examined MDMA’s acute social effects, findings vary widely across subjective and behavioural domains. Methods We conducted a systematic review of placebo-controlled studies investigating the acute effects of MDMA on social cognition in adults. Outcomes included self-reported social and emotional experience, task-based measures of social cognition and behaviour, and relevant physiological and neurobiological indices. Studies administering MDMA as the sole intervention were included. Results Across 75 studies, MDMA reliably enhanced subjective social experience, including feelings of sociability, emotional openness, closeness, and emotional empathy. In contrast, behavioural manifestations of prosociality, such as cooperation and trust in economic or performance-based tasks, were inconsistent and strongly context dependent. Behavioural and neuroimaging measures showed reduced accuracy in identifying negative social cues, including fear and anger, but no study used signal-detection metrics to discriminate genuine perceptual blunting from a shift in response criterion. Neuroimaging findings were from small, methodologically heterogeneous samples. Conclusions MDMA consistently alters how social interactions are experienced, but subjective changes do not reliably translate into observable prosocial behaviour. MDMA reduces accuracy in identifying negative social cues, particularly fear and anger, but whether this reflects a specific blunting of threat processing or a shift in response bias and salience detection remains unresolved. Clarifying these mechanisms has implications for understanding MDMA’s therapeutic potential in conditions characterised by heightened social threat and avoidance.
ER -